XML 87 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 28, 2019
Sep. 29, 2018
Cash flows from operating activities:    
Net income $ 391,529 $ 408,642
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 28,917 28,184
Deferred income taxes 1,817 278
Depreciation 42,168 44,710
Amortization of intangibles 38,151 38,101
Change in operating assets and liabilities:    
Decrease in accounts receivable 57,897 36,893
Increase in inventories (83,973) (47,826)
Increase in other current assets (6,259) (21,091)
Increase in other assets (9,302) (3,251)
Decrease in accounts payable and other current liabilities (493) (93,637)
Increase in deferred revenue and customer advances 34,926 23,085
Effect of the 2017 Tax Cuts & Jobs Act (3,229) 12,450
Decrease in other liabilities (40,957) (3,641)
Net cash provided by operating activities 451,192 422,897
Cash flows from investing activities:    
Additions to property, plant, equipment and software capitalization (110,205) (64,215)
Asset acquisitions   (31,486)
Investment in unaffiliated companies (7,250) (7,615)
Purchases of investments (35,523) (908,147)
Maturities and sales of investments 978,419 2,269,181
Net cash provided by investing activities 825,441 1,257,718
Cash flows from financing activities:    
Proceeds from debt issuances 600,362 10
Payments on debt (390,482) (850,000)
Payments of debt issuance costs (2,932)  
Proceeds from stock plans 34,311 42,377
Purchases of treasury shares (1,909,700) (816,649)
Proceeds from (payments for) derivative contracts 6,900 (2,181)
Net cash used in financing activities (1,661,541) (1,626,443)
Effect of exchange rate changes on cash and cash equivalents (6,723) (7,118)
(Decrease) increase in cash and cash equivalents (391,631) 47,054
Cash and cash equivalents at beginning of period 796,280 642,319
Cash and cash equivalents at end of period $ 404,649 $ 689,373